Bill & Melinda Gates Foundation — Full Portfolio
29 tracked investments · listed companies and verified rows first
ClaremontBio manufactures sample preparation devices and reagents for molecular diagnostics and genomic research, including cell lysis, DNA/RNA extraction, and detection systems.
BiotechDeep TechHardwareMedical DevicesUpland, US
Gary Blackburn(CEO)
Co-investorsIn-Q-Tel
CDD provides software for collaborative research and discovery in biological and chemical sciences, serving scientists and organizations globally.
AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareSaaS
Barry Bunin(Founder & CEO)
A searchable database of peer-reviewed evidence on the benefits of immunization, designed for child health advocates, researchers, and policymakers.
Digital HealthHealthtechImpact & Social GoodBaltimore, US
Co-investorsICONIQ
Neurosynaptic Communications provides customized healthcare delivery solutions and telemedicine services designed for primary healthcare centers and underserved regions.
AI & Machine LearningDigital HealthHealthtechImpact & Social GoodSaaS
Sameer Sawarkar(Founder and CEO)inRajeev Kumar(Founder and COO)in
Co-investorsHealthQuadVenturEast
Pula is an investment and advisory firm that operates an accelerator program in partnership with Nigeria's Sovereign Investment Authority, supporting early-stage ventures in climate resilience, agricultural technology, insurance technology, and regulatory technology across African markets.
AgTechClimate TechInsurTechNairobi, ZA
Thomas Njeru(Co-Founder and CEO)inRose Goslinga(Co-Founder and President)in
Co-investorsAccionInternational Finance CorporationMulago FoundationTLcom CapitalIFC
Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth.
Digital HealthFemTechHealthtechMedical DevicesSan Ramon, US
Neil P. Ray(Executive Officer, Director)inMichael Nagel(Chief Executive Officer)in
BoardCharles McDonald(Director)John Maroney(Director)
Co-investorsBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesAvestria VenturesRhia Ventures+3 more
Sanaria develops malaria vaccines designed to prevent infection in at-risk populations worldwide, including pregnant women and children, with long-term goals of mass immunization campaigns and disease elimination.
BiotechHealthtechImpact & Social GoodMedical Devices
Stephen L. Hoffman(CEO)
Stellapps builds the SmartMoo™ full-stack IoT platform that digitizes and optimizes milk production, procurement, and cold-chain management using sensors, big data, and machine learning.
AgTechFoodTechIoTSaaSBangalore, IN
Ranjith Mukundan(CEO)inRamakrishna Adukuri(Founder)inPraveen NaleRavishankar ShiroorinVenkatesh SeshasayeeinYawar Usmaniin
1575275080338.jpg?format=auto&w=1920&q=75)
Co-investors500 GlobalBlue Ashva CapitalCelesta CapitalCelesta CapitalQualcomm VenturesBlume Ventures+2 more
Syntis Bio develops oral therapies that use the biology of the small intestine to treat conditions ranging from rare genetic disorders to common diseases.
BiotechDeep TechDigital HealthHealthtechBoston, US
Rahul Dhanda(Executive Officer, Director)inCarlo Giovanni Traverso(Director)Robert Langer(Director)
BoardTeymour Boutros-Ghali(Director)inTEYMOUR BOUTROS-GHALI(Director)inMartin Madaus(Director)
Co-investorsBold Capital PartnersCerity Partners VenturesPortal InnovationsSafar Partners
Aphea.Bio develops bioinsecticides targeting sap-sucking insects that damage crops, in partnership with Bayer to accelerate their development.
AgTechBiotech
Isabel Vercauterenin
Co-investorsAstanor VenturesEuropean Circular Bioeconomy FundInnovation IndustriesPMVV-Bio VenturesAIF+1 more
BioSurfaces develops medical devices, 3D tissue engineering scaffolds, and personal care products using its proprietary Bio-Spun nanofiber technology.
BiotechMedical DevicesNew MaterialsAshland, US
Tina M Phaneuf(Executive Officer and Director of Manager)inMatthew D. Phaneuf(Executive Officer and Director of Manager)in
BoardThomas L Barrette(Director of Manager)
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.
BiotechDeep TechHealthtechBoston, US
Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)
BiotechCambridge, US
Bobby Herrara(Executive Officer)Bobby Brooke Herrera(Cofounder)Ann DeWitt(Director)Prashant Chouta(Executive Officer, Director)
Co-investorsBlue Ivy VenturesCastor VenturesKhosla Ventures
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+7 more
Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women.
BiotechFemTechHealthtech
Colleen Acosta, PhD(CEO, Co-Founder)Johan van Hylckama Vlieg, PhD(CSO, Co-Founder)
Co-investorsAngelini VenturesIndaco Venture PartnersOMX VenturesSofinnova Partners
GBS is a German manufacturer of modular email security and management software, including its iQ.Suite, offering threat protection alongside governance, risk and compliance (GRC) capabilities.
CybersecurityEnterprise SoftwareSaaS
Co-investorsWalnut Venture Associates
Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.
BiotechCambridge, US
Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)inMichael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)
Co-investorsCycad Group LLCLux CapitalMC Healthcare VenturesAdvent Life SciencesAlexandriaAuriga Partners+1 more
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechWellness & FitnessSacramento, US
J. Bruce German(Co-founder)David Mills(Co-founder)inCarlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)inMichael Johnson(Executive Officer, Director)
Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundLongitude CapitalSpruce Capital Partners
Inventprise is a clinical-stage vaccine developer using its proprietary Hydrazide-PEG-Hydrazide (Hz-PEG-Hz) linker conjugation platform to create conjugate vaccines, including a lead pediatric pneumococcal conjugate vaccine (IVT PCV-25) and candidates for Group B Streptococcus and mRNA-based vaccines.
BiotechHealthtechRedmond, US
Subhash Kapre(Manager, Co-CEO)inPradip Ghate(Chief Operating Officer)inDavid Goesling(Chief Financial Officer)inYves Leurquin(Manager, Co-CEO)in
Loowatt develops a patented waterless, chemical-free flush toilet that seals waste in a lining and offers end-to-end sanitation-as-a-service, including servicing and processing of waste into biogas and fertiliser via anaerobic digestion.
Circular EconomyCleantechHardware
Virginia Gardiner(CEO + Founder)in
.png)
Co-investorsAngel AcademeOxford Investment Opportunity Network (OION)
Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity.
AI & Machine LearningBiotechHealthtechSeattle, US
Ivan Liachko(Executive Officer, Director, Promoter)inShawn Sullivan(Executive Officer, Promoter)in
Co-investorsCongruent VenturesHemi Ventures, LlcAlliance of Angels
Puna Bio develops agricultural inputs using extremophile microorganisms from the Argentine Puna to promote sustainable farming practices.
AgTechBiotechClimate TechPuna, AR
Franco Martínez LevisinElisa Violeta BertiniinCarolina BelfioreinMaría Eugenia Faríasin
Co-investorsCapria VenturesAt One VenturesBuilders VCDalus CapitalGLOCAL LatamSOSV
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Toronto Innovation Acceleration PartnersAmplitude Venture Capital
SwipeRx operates a digital network for independent pharmacies and pharmacy professionals across Southeast Asia, offering community tools and a purchasing platform for buying quality medicines.
B2B MarketplacesDigital HealthHealthtech
Farouk Meralli(Founder)in
Co-investorsPatamar CapitalSpiral VenturesMDI Ventures
Synvect develops ngSIT (next-generation sterile insect technique) technology to control mosquito-borne disease vectors through genetic engineering.
AgTechBiotechClimate TechDeep TechHealthtechImpact & Social GoodSan Diego, US
Nikolay Kandul(Co-founder & CEO)inOmar Akbari(Co-founder & CSO)Pooja Y. Patel(Co-founder & CBO)inRavi Solanki(Co-founder)in
Co-investorsService Provider CapitalAntlerNuFundRedbudRedbud VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.